Status:
UNKNOWN
Cognitive Remediation in Alcohol Disorders
Lead Sponsor:
University Hospital, Caen
Conditions:
Alcohol Disorders
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The individual and societal cost of alcohol use disorders (TUAL), present in 10% of the population in France, is considerable. Despite psychotherapeutic and drug addiction treatment, the relapse rate ...
Eligibility Criteria
Inclusion
- Patient male or female aged 18 to 60, French speaking and affiliated to the social security system
- Patient with TUAL (DSM-5) at the forefront of alcohol use disorders at the time of inclusion
- Patient with neuropsychological disorders objectified on BEARNI (BEARNI for Brief Evaluation of Alcohol-Related Neuropsychological Evaluation, Ritz et al., 2015 cut-off cognitive score = 13, adding a point for patients with bachelor level or lower) and confirmed at the neuropsychological checkup showing pathological performance (at least two free or total recalls of RL / RI 16 \<-1.65 and / or RBMT IGM \<-1.65 OR number of persecutory or deficit errors at MCST \<-1.65 and / or at least two BADS subtests with a score of \<or = 2 (except temporal judgment)). Evaluation (BEARNI) at least 48h after stopping benzodiazepines
- Patient weaned of alcohol, that is to say between 5 and 21 days after stopping alcohol, after disappearing signs of withdrawal (Cushman score \<2) and stopping benzodiazepines
- First hospitalization type day hospital (not necessarily first weaning)
- Patient having been informed of the study and being able to give written informed consent.
Exclusion
- Patient with severe and long-lasting neurological complications related to alcohol (Korsakoff syndrome, fetal alcohol syndrome, ...)
- Patient with a disorder of severe use of another psychoactive substance according to DSM-5, except tobacco
- Patient with motor or sensory deficit making cognitive remediation impossible
- Patient previously included or already included in another biomedical research
- Homeless patient
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03335215
Start Date
February 1 2018
End Date
February 1 2020
Last Update
November 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.